Given that this molecule is involved in characteristic processes of ILD, such as vascular dysfunction, inflammation and pulmonary fibrosis [2,11,12,13,14,30], ET-1 can constitute a promising candidate biomarker of this complex group of diseases. This evidence concerns the gene EDN1 and interstitial lung disease.